Time
Days to earnings14
Next print2026-10-30
WindowBMO
Fiscal2026-09-30
NASDAQ · HEALTHCARE · BIOTECHNOLOGY
REGN
Regeneron Pharmaceuticals Inc primary
762.81
Full stocks workspace →+16.27+2.2%
Street
Consensus EPS15.992
Consensus revenue4.5B
EPS high / low17.68 / 14.53 · 19.7% · n=21
Rev / avg0 / — · 15.945 / 15.997
Options
IV front28.3%
Implied move6.3%
Put/call full0.82
Put/call front0.46
Short interest
Short shares2.2M / 2.5M · -14.89%
Days to cover2.49
Avg vol · float863.8K · 100.9M
Short % float2.13%
| Date | DTE | Next | Close | Cons. EPS | IV front % | Implied | Ret 5d | Ret 10d | Ret 20d | Ret 30d | EPS high / low | Dispersion | Analysts | P/C | Peers rpt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-12 | 14 | 2026-10-30 | 762.81 | 15.992 | 28.3% | 6.3% | +5.0% | +1.4% | -3.9% | -4.0% | 17.68 / 14.53 | 19.7% | 21 | 0.82 | 0 | |
| 2026-10-09 | 15 | 2026-10-30 | 746.54 | 15.992 | 29.8% | 7.1% | +1.5% | -5.3% | -4.5% | -7.6% | 17.68 / 14.53 | 19.7% | 21 | 0.82 | 0 | |
| 2026-10-08 | 16 | 2026-10-30 | 739.57 | 15.992 | 28.8% | 7.1% | +0.6% | -7.1% | -6.8% | -9.2% | 17.68 / 14.53 | 19.7% | 21 | 0.83 | 0 | |
| 2026-10-07 | 17 | 2026-10-30 | 742.12 | 15.992 | 28.3% | 7.1% | -2.1% | -7.4% | -8.1% | -11.0% | 17.68 / 14.53 | 19.7% | 21 | 0.83 | 0 | |
| 2026-10-06 | 18 | 2026-10-30 | 738.72 | 15.992 | 28.3% | 7.3% | -1.6% | -8.1% | -8.8% | -10.8% | 17.68 / 14.53 | 19.7% | 21 | 0.83 | 0 | |
| 2026-10-05 | 19 | 2026-10-30 | 726.47 | 16.015 | 27.3% | 7.2% | -3.4% | -9.0% | -12.2% | -12.9% | 17.68 / 14.53 | 19.7% | 20 | 0.83 | 0 | |
| 2026-10-02 | 17 | 2026-10-27 | 735.20 | 15.945 | 29.3% | 7.7% | -6.7% | -6.3% | -12.8% | -11.1% | 17.68 / 14.53 | 19.8% | 20 | 0.83 | 0 | |
| 2026-10-01 | 18 | 2026-10-27 | 734.81 | 15.945 | 30.3% | 8.1% | -7.7% | -6.9% | -13.8% | -12.6% | 17.68 / 14.53 | 19.8% | 20 | 0.83 | 0 | |
| 2026-09-30 | 19 | 2026-10-27 | 758.27 | 15.945 | 28.3% | 7.7% | -5.4% | -2.1% | -8.0% | -6.4% | 17.68 / 14.53 | 19.8% | 20 | 0.83 | 0 | |
| 2026-09-29 | 20 | 2026-10-27 | 750.51 | 15.945 | 29.8% | 8.2% | -6.6% | -3.0% | -6.1% | -6.9% | 17.68 / 14.53 | 19.8% | 20 | 0.81 | 0 |
Linked names and their last print
| Peer | Name | Score | Last qtr | Last surprise | Reaction | 1-day close | DTE (full) |
|---|---|---|---|---|---|---|---|
| AMGN primary | Amgen Inc | 0.49 | 2026Q2 · 2026-08-04 | +12.3% | +0.9% | 407.83 | 16 · 2026-10-12 |
| VRTX primary | Vertex Pharmaceuticals Inc | 0.39 | 2026Q2 · 2026-08-03 | +1.2% | +0.1% | 478.71 | 15 · 2026-10-12 |
| GILD primary | Gilead Sciences Inc | 0.32 | 2026Q2 · 2026-08-03 | +4.5% | 0.0% | 135.25 | 13 · 2026-10-12 |
| Fiscal qtr | Report date | Window | Actual EPS | Surprise % | Beat | Reaction | 1-day result | Vol ×10d | Post 10d | Review |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2026-07-30 | BMO | 12.53 | +56.6% | Beat | +0.9% | +5.2% | 1.87× | +9.2% | Review |
| 2026Q1 | 2026-04-29 | BMO | 9.47 | +6.4% | Beat | -3.6% | -2.7% | 2.78× | +4.9% | Review |
| 2025Q4 | 2026-01-30 | BMO | 11.44 | +6.4% | Beat | +0.6% | -1.7% | 1.47× | +8.3% | Review |
| 2025Q3 | 2025-10-28 | BMO | 11.83 | +22.7% | Beat | +4.6% | +6.9% | 2.53× | +3.1% | Review |
| 2025Q2 | 2025-08-01 | BMO | 12.89 | +52.7% | Beat | +6.9% | -4.1% | 1.83× | +3.9% | Review |
| 2025Q1 | 2025-04-29 | BMO | 8.22 | -3.1% | Miss | -8.0% | +1.3% | 2.79× | +0.9% | Review |
| 2024Q4 | 2025-02-04 | BMO | 12.07 | +7.9% | Beat | -2.5% | +7.2% | 1.80× | -1.6% | Review |
| 2024Q3 | 2024-10-31 | BMO | 12.46 | +6.5% | Beat | -5.2% | -4.2% | 2.97× | -6.6% | Review |
| 2024Q2 | 2024-08-01 | BMO | 11.56 | +8.9% | Beat | -1.7% | +3.0% | 2.24× | +7.5% | Review |
| 2024Q1 | 2024-05-02 | BMO | 9.55 | -5.4% | Miss | -0.4% | +4.2% | 2.27× | +3.2% | Review |